Rise Creative launches the remedy to CNS Healthcare’s previous web ailments.
CNS Healthcare is on a mission to advance safe and effective pharmaceuticals to improve the quality of healthcare world-wide. And now with the fresh new face of their website launched, we expect CNS to reenter the healthcare industry with strength and confidence. CNS partnered with Rise to redesign and rebrand in an effort to match their advancements in the industry with their online presence.
The Rise Team has given CNS a new and exciting vibrant look, pertinent and dynamic content, significant layout updates and interactivity to improve the visitor experience and promote usability.
The site includes a new feature called the “Symptom Checker” that allows visitors to pinpoint their symptom to determine what medical condition they may be suffering as well as the ability to receive updated news and information about clinical trials pertaining to that condition.
An enhanced user experience has been designed for those with interest in participating in a clinical trial or people seeking education on various mental and medical conditions. The site was designed to help visitors more easily navigate the process of getting started in a clinical trial with step-by-step assistance and promote retention while reducing the possibility of confusion.
“The new site is a reflection of our growth and continued improvement. It’s representative of our pace-setting approach to patient recruitment. Our vision is to be the best clinical trial company in America and our mission is to advance safe and effective pharmaceuticals in order to improve the quality of healthcare world-wide” stated Scott West, CNS Healthcare President and CEO. “The site ties in with our strategic long-term goals and was an important next step in the corporate rebranding that we initiated in January ‘09?, said Carrie Lockwood, CNS Healthcare Director of Marketing.
Be sure to check-in to CNS Healthcare and keep looking to Rise to prescribe the perfect cure for more “websick” websites!








